Jul 26, 2013 | Research News
Phase 3 Studies of Afrezza Ultra-fast Inhaled Insulin On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza is an ultra-rapid-acting mealtime insulin...
Jun 22, 2013 | Technology Updates
Kelly Close, editor-in-chief of diatribe, writes, in the June issue of diatribe about her experiences on a 5-day trial on the bionic pancreas: I’m now exactly eleven days out of the five-day Boston University/Massachusetts General Hospital bionic pancreas1...
Jun 21, 2013 | Featured, Recommended Books
Cheating Destiny: Living with Diabetes by James S. Hirsch In Cheating Destiny, the best-selling author James S. Hirsch offers an incisive, sometimes surprising portrait of diabetes in America. Hirsch is intimately familiar with the disease: he has lived with type 1...